Related Experiment Video
Updated: Aug 16, 2025
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.9K
TB-related technical enquiries received in Japan, 2017-2019
M Urakawa1, A Yasukawa1, Y Hoshino1
1Research Institute of Tuberculosis, Tokyo, Japan.
Public Health Action
|December 23, 2022
Summary
Technical enquiries in Japan reveal a high demand for tuberculosis (TB) diagnosis and treatment support. Findings suggest maintaining specialized TB institutions to aid healthcare professionals and the public.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Health Services Research
Background:
- Japan is classified as an intermediate tuberculosis (TB) burden country.
- Understanding the nature and frequency of TB-related technical enquiries is crucial for optimizing public health strategies.
- The Research Institute of Tuberculosis in Japan serves as a key resource for addressing TB-related queries.
Purpose of the Study:
- To analyze TB-related technical enquiries received by the Research Institute of Tuberculosis in Japan.
- To identify trends in enquiry types, sources, and geographical distribution.
- To inform policy and resource allocation for TB control in Japan.
Main Methods:
- A cohort study design was employed.
- Analysis of 2,197 TB-related technical enquiries received between January 2017 and December 2019.
- Enquiries were categorized by source, enquirer type, and subject matter.
Main Results:
- An average of 61.0 enquiries per month were received, with significant regional variations in enquiry rates.
- The majority of enquirers were from local governments (72.1%) and healthcare facilities (14.0%), primarily nurses (54.9%) and medical doctors (17.8%).
- The most common topics were TB diagnosis and treatment (22.8%), contact investigations (17.5%), and TB in foreigners (15.7%).
Conclusions:
- Frequent enquiries regarding TB diagnosis and treatment highlight a need for continued expert support.
- Specialized TB institutions with dedicated physicians are essential for providing technical assistance.
- The findings underscore the importance of accessible expertise for managing TB in Japan.
More Related Videos
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
5.8K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.3K
Related Concept Videos
01:26Pulmonary Tuberculosis IV
186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
01:29Pulmonary Tuberculosis I
297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
01:28Pulmonary Tuberculosis V
225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
01:31Pulmonary Tuberculosis III
410
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
410
01:28Pulmonary Tuberculosis II
296
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
296